Daiichi Sankyo Co Ltd, D4S:FRA directors and dealings

Price (EUR)16.01
Today's Change-0.365 / -2.23%
Shares traded600.00
1 Year change-30.84%
Beta1.0109

Data delayed at least 15 minutes, as of Feb 16 2026 11:20 GMT.

More ▼

Add to Your Portfolio

Name

Currency

Directors & dealings data is unavailable for this security.

Directors & Officers

Click or tap a row for biographies

Name	Title	Compensation	Age	Officer since
Sunao Manabe	Chairman of the Board, Chairman of the Executive Board, Representative Director	302.00mJPY	70	2012
Takaaki Nishii	Chairman of the Board of Directors, Independent Director	--	65	2023
Hiroyuki Okuzawa	President, Executive President, Chief Executive Officer, Representative Director	153.00mJPY	62	2018
Koji Ogawa	Senior Managing Executive Officer, Chief Financial Officer, Head of Global Corporate Planning and Management	--	--	2017
Tomohiro Kodama	Executive Officer, Director of Finance & Accounting in Global Corporate Planning & Management	--	--	2025
Takashi Matsumoto	Senior Managing Executive Officer, Chief Human Resources Officer, Head of Global HR, Director	--	61	2021
Shizuko Ueno	Managing Executive Officer, Chief Director of Medical Affairs, Manager of Japan Business Unit, Director	--	59	2022
Hiroto Kashiwase	Managing Executive Officer, Manager of Technology Unit	--	--	2020
Hiroshi Masumoto	Managing Executive Officer, Director of Global DX Data Intelligence	--	--	2022
Nobuo Murakami	Managing Executive Officer, Head of Global Corporate Strategy, CStO(Chief Strategy Officer)	--	--	2021
Kiminori Nagao	Managing Executive Officer, Manager of ASCA Business Unit, Chief Director of ASCA Business	--	--	2021
Naoto Tsukaguchi	Managing Executive Officer	--	--	2021
Hiroya Senda	Executive Officer, Chief Director of Pharmaceutical Sales in Japan Business Unit	--	--	2022
Akihiro Tokumoto	Executive Officer, Director of Human Resource	--	--	2024
Kentaro Asakura	Executive Officer, Director of Corporate Communications in Global Corporate Planning & Management	--	--	2025
Junichi Ashihara	Executive Officer, Senior Director of Production in Main Technology Unit	--	--	2024
Shinya Ikeda	Executive Officer, Senior Director of Research and Development Planning and Promotion in Main Research and Development Unit	--	--	2025
Akihiro Inoguchi	Executive Officer, Senior Director of Development in Main Research and Development Unit	--	--	2022
Tetsuya Iwabuchi	Executive Officer	--	--	2023
Toshi Kajiro	Executive Officer	--	--	2022
Chiaki Matsumoto	Executive Officer, Director of Research and Development of Development Supervision Unit in Main Research and Development Unit	--	--	2025
Hideaki Noji	Executive Officer, Director of Business Administration in Japan Business Unit	--	--	2024
Koichi Nonaka	Executive Officer, Senior Director of Technology Development in Main Technology Unit	--	--	2023
Satoru Ogawa	Executive Officer, Director of Secretariat	--	--	2022
Tetsuya Ohira	Executive Officer, Director of Corporate Planning in Corporate Planning & Management	--	--	2021
Hanako Saito	Executive Officer	--	--	2023
Akio Sakurai	Executive Officer	--	--	2020
Koji Sato	Executive Officer, Chief Director of Technology, Senior Director of Technology Planning	--	--	2023
Kenji Shigeta	Executive Officer	--	--	2023
Atsushi Tsukamoto	Executive Officer, Director of Global Corporate Strategy	--	--	2022
Abe Yuki	Executive Officer, Chief Director of Research and Development, Senior Director of Research	--	--	2024
Joseph Keller	Manager of Oncology Business Unit, President and CEO of Subsidiaries, Director	--	62	2025
Yo Honma	Independent Director	--	--	2024
Reiko Kinoshita	Independent Director	--	61	2025
Yasuhiro Komatsu	Independent Director	--	66	2022
Akihiro Watanabe	Independent Director	--	66	2025

More ▼

Data Provided by LSEG

All markets data located on FT.com is subject to the FT Terms & Conditions

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Daiichi Sankyo Co Ltd

Select symbol

Daiichi Sankyo Co Ltd

ApplyActions

Your alerts

Directors & Officers